RAPT Therapeutics, Inc.
NASDAQ: RAPT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Brian Russell Wong
- Employees
- 67
- Headquarters
- South San Francisco, United States
- IPO year
- 2019
- Market cap
- $959.3M
- Website
- https://www.rapt.com
Loading RAPT…
Loading profile data…Frequently asked questions about RAPT
What does RAPT Therapeutics, Inc. (RAPT) do?
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies. These treatments are aimed at addressing critical unmet medical needs for patients battling oncology and inflammatory diseases. Its prima...
Where does RAPT trade?
RAPT Therapeutics, Inc. (RAPT) trades on the NASDAQ Global Market.
What sector is RAPT in?
RAPT Therapeutics, Inc. (RAPT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of RAPT Therapeutics, Inc.?
Brian Russell Wong is the chief executive officer of RAPT Therapeutics, Inc. (RAPT).
Where is RAPT Therapeutics, Inc. headquartered?
RAPT Therapeutics, Inc. is headquartered in United States.
Does RAPT pay a dividend?
RAPT Therapeutics, Inc. (RAPT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RAPT go public?
RAPT Therapeutics, Inc. (RAPT) completed its initial public offering in 2019.